Life Sciences (International Firms) | Greater China Region

Sidley Austin LLP fields a top-notch team handling a range of work in the life science space, including transactions, FCPA investigations and antitrust matters as well as related IP issues. It is particularly skilled in undertaking licensing as well as financing matters. The team advises international companies on corporate, regulatory and compliance issues. The firm is also active on matters relating to data privacy.

Arnold & Porter's growing life sciences team maintains an active practice by engaging with well-known pharmaceutical and medical device clients. It is able to advise across the spectrum of life sciences mandates and offers particular regulatory strength in enforcement and compliance-related issues. The team is well placed to handle investigations, litigation and cross-border transactional work on behalf of life sciences companies. The firm is additionally noted for its specialism in product liability matters.

The renowned healthcare and life sciences group at Baker McKenzie remains active on M&A and commercial agreements in the healthcare industry, advising on regulatory compliance, licensing, joint venture, distribution agreements. The law firm is equally well placed to handle drug procurement, pricing, and product liability and recall issues. The team is also noted for its expertise in IP protection as well as patent and trade mark prosecution.

Bird & Bird's life sciences and healthcare team is recognised for its strength in contentious and non-contentious IP issues, including patent litigation, licensing and portfolio management. The team advises on clinical trials and is increasingly active on corporate and transactional matters. The firm is noted for its capabilities in cross-border matters involving Asian and European jurisdictions.

Goodwin's has a burgeoning practice in life sciences, actively advising on a wide range of transactional matters, including financings and investments. In addition to regulatory advice, it is well-versed at handling licensing and partnership agreements. The firm fields a group of experts with previous experience as scientists.

Ropes & Gray LLP houses a highly reputed life sciences practice which offers expertise in both regulatory and transactional matters, as well as related IP and FCPA issues. The team advises US and Asian companies on their Chinese operations and cross-border matters, including licensing and collaboration agreements. It is active on M&A and financing projects for a strong roster of pharmaceutical, biotechnology and medical device companies.

DLA Piper LLP's life sciences team skilfully provides a fully rounded and globally integrated life science practice, ranging from corporate/M&A, employment and capital markets to investigations. Its partners in Hong Kong and Shanghai cater to clients from all areas of life science including pharmaceuticals, biotechnology and medical devices. The team is also active on regulatory issues, data protection and IP work for its life sciences clientele.

The China life sciences department at Morrison Foerster LLP possesses strong technical abilities and broad industrial experience. Its key areas of focus include IP and due diligence matters. The team advises clients on IP prosecution and portfolio management. It is well-versed at handling corporate matters including outbound investments, commercial partnerships, joint ventures and M&A deals.

CMS possesses a dynamic life sciences and healthcare practice in China with significant international capability. It handles a high volume of inbound work, often assisting foreign players in the pharmaceutical and medical device sectors with their Chinese transactions. CMS offers further expertise in patent issues and relevant litigations. The team has the ability to advise on multi-jurisdictional matters.

Freshfields boasts a growing Life Science operation out of its offices in Beijing, Shanghai and Hong Kong. The firm has notable expertise in both transactional and regulatory work, handling license agreements, divestment, acquisition, privatisation, exit deals, as well as antitrust matters. Freshfields is regularly sought after by multinational companies in the pharmaceutical, healthcare and science and technology sectors. The team also advises on multi-jurisdictional matters and acts on IP cases.

Kirkland & Ellis' Greater China team offers expertise in corporate investigations and regulatory work relating to Life Sciences. They count among their clients a number of multinational pharmaceutical and healthcare companies. Through utilising their international reach, the team is also adept at advising private equity and venture capital companies on transactional matters within the life sciences.

Paul Hasting is growing its presence in the life sciences and healthcare space with a noteworthy track record of assisting pharmaceutical companies with internal and governmental investigations, ABAC compliance and risk assessments. The firm's transactional capability is sought after by pharmaceutical companies and investors to handle acquisitions and investments. It also swiftly deals with disputes over licensing agreements and shareholder agreements. Additionally, the team is also adept at data privacy and cybersecurity compliance.